Helyx Industries S.p.A. (BIT:HLX)

Italy flag Italy · Delayed Price · Currency is EUR
0.7760
-0.0040 (-0.51%)
Feb 11, 2026, 5:00 PM CET
Market Cap19.10M -3.5%
Revenue (ttm)925.87K +120.0%
Net Income-5.30M
EPS-0.22
Shares Out24.48M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume80,000
Average Volume31,550
Open0.7800
Previous Close0.7800
Day's Range0.7660 - 0.7960
52-Week Range0.6800 - 1.4000
Beta0.78
RSI46.10
Earnings DateMar 27, 2026

About Helyx Industries

Helyx Industries S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseas... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 18
Stock Exchange Borsa Italiana
Ticker Symbol HLX
Full Company Profile

Financial Performance

In 2024, Helyx Industries's revenue was 767,929, an increase of 1059.87% compared to the previous year's 66,208. Losses were -5.94 million, 23.8% more than in 2023.

Financial Statements